Search by Drug Name or NDC

    NDC 76045-0103-20 ONDANSETRON 4 mg/2mL Details

    ONDANSETRON 4 mg/2mL

    ONDANSETRON is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is ONDANSETRON HYDROCHLORIDE.

    Product Information

    NDC 76045-0103
    Product ID 76045-103_b71a45e3-2b90-4199-b88b-fef27cb394fc
    Associated GPIs 5025006505E520
    GCN Sequence Number 062183
    GCN Sequence Number Description ondansetron HCl/PF SYRINGE 4 MG/2 ML INJECTION
    HIC3 H6J
    HIC3 Description ANTIEMETIC/ANTIVERTIGO AGENTS
    GCN 97968
    HICL Sequence Number 033598
    HICL Sequence Number Description ONDANSETRON HCL/PF
    Brand/Generic Generic
    Proprietary Name ONDANSETRON
    Proprietary Name Suffix n/a
    Non-Proprietary Name ONDANSETRON HYDROCHLORIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 4
    Active Ingredient Units mg/2mL
    Substance Name ONDANSETRON HYDROCHLORIDE
    Labeler Name Fresenius Kabi USA, LLC
    Pharmaceutical Class Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202253
    Listing Certified Through 2024-12-31

    Package

    NDC 76045-0103-20 (76045010320)

    NDC Package Code 76045-103-20
    Billing NDC 76045010320
    Package 24 BLISTER PACK in 1 CARTON (76045-103-20) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-103-00) / 2 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2015-12-10
    NDC Exclude Flag N
    Pricing Information N/A